KAPLANOVÁ, Jana, Marcela TOMÍŠKOVÁ, Lenka BABIČKOVÁ, Olga KUBOVÁ, Ivana PÁLKOVÁ, Pavel ŠLAMPA and Jana SKŘIČKOVÁ. Chemotherapy pacltacel, carboplatin and etoposide with concurrent radiotherapy in the treatment of locoregionally advanced non small cell lung cancer (NSCLC). Lung Cancer. 2003, vol. 41, sup 2, p. 284. ISSN 0169-5002.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Chemotherapy pacltacel, carboplatin and etoposide with concurrent radiotherapy in the treatment of locoregionally advanced non small cell lung cancer (NSCLC)
Authors KAPLANOVÁ, Jana (203 Czech Republic, guarantor), Marcela TOMÍŠKOVÁ (203 Czech Republic), Lenka BABIČKOVÁ (203 Czech Republic), Olga KUBOVÁ (203 Czech Republic), Ivana PÁLKOVÁ (203 Czech Republic), Pavel ŠLAMPA (203 Czech Republic) and Jana SKŘIČKOVÁ (203 Czech Republic).
Edition Lung Cancer, 2003, 0169-5002.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30203 Respiratory systems
Country of publisher Czech Republic
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 1.798
RIV identification code RIV/00216224:14110/03:00009441
Organization unit Faculty of Medicine
Keywords in English non small cell lung cancer; locoregionally advanced; chemotherapy;
Tags chemotherapy, locoregionally advanced
Changed by Changed by: prof. MUDr. Jana Skřičková, CSc., učo 1808. Changed: 19/1/2004 09:42.
Abstract
Forty-three patients with locoregionally advanced NSCL was treated, Tumour was radically resected in 30% of patients. Therapeutic response to CR+PR was achieved in 58% pts.; 44% reached a 1-year suvival, 9% two years.
Links
MSM 141100003, plan (intention)Name: Zevní prostředí - karcinogeneze - onkologie
Investor: Ministry of Education, Youth and Sports of the CR, Environment - carcinogenesis - oncology
PrintDisplayed: 19/9/2024 07:03